Cognixion Corporation

Cognixion Corporation develops innovative noninvasive brain-computer interfaces to enhance communication for individuals with complex disabilities, employing cutting-edge technology to improve accessibility and quality of life. Cognixion Corporation is focused on creating advanced brain-computer interfaces that facilitate communication for those with disabilities. The company is headquartered in Santa Barbara, US, and was co-founded by Andreas Forsland and Cris Lizama, who are also the current CEOs. In November 2021, Cognixion raised USD 12 mn in SEED funding led by Prime Movers Lab, with participation from Amazon, Northwell Holdings, and Volta Circle, bringing the total amount raised to USD 12 mn with three total deals.

Cognixion specializes in pioneering noninvasive brain-computer interfaces (BCIs) designed to enhance communication and control for individuals with complex disabilities. Its core product, Axon-R, employs advanced AI technology to facilitate interaction through various input methods, such as mental commands, eye movements, and head gestures. This suite of AI-powered Assisted Reality applications addresses significant challenges in accessibility and communication, primarily targeting users with neurological impairments. The company collaborates with top health systems to co-develop clinical applications that cater to patients throughout their healthcare journey, particularly in neurology.

Cognixion's solutions are utilized across various geographical markets, including North America and Europe, directly impacting individuals, healthcare providers, and researchers in the neurotechnology space. Cognixion generates revenue through direct sales of its innovative assistive technologies and clinical applications, including its flagship product, Axon-R. The company operates on a B2B model, partnering with healthcare institutions to implement its technologies within existing patient care frameworks. Transactions are structured around subscription-based agreements and partnerships, allowing healthcare providers to integrate Cognixion's offerings into their service delivery.

Additionally, Cognixion provides demo opportunities to potential clients, facilitating a firsthand experience with its solutions before purchase. This approach underscores the company’s commitment to enhancing accessibility through neurotechnology while fostering strong relationships with its client base in the healthcare sector. Cognixion plans to utilize the USD 12 mn raised in its SEED funding round to develop new adaptive interfaces for its Assisted Reality technology. The company aims to expand its presence in North America and Europe, focusing on integrating its solutions into additional healthcare settings by late 2023 to early 2024.

Through these initiatives, Cognixion is positioning itself to further address accessibility challenges in communication for individuals with complex disabilities.